Coloplast A/S logo

Coloplast A/S

TickerCOLO-B.COVenueCPHSectorHealthcarePrimary listingBeta0.56
DKK 471.4-0.17%
FinScore62

Coloplast A/S is a Denmark-based company in the Healthcare sector with a market capitalisation of $16.0B. Its FinScore is 62/100; its highest-scoring layer is Quality (73) and its lowest is Growth (40). The shares trade at 38.5x trailing earnings and are down 12% year to date.

Market cap
$16.0B
P/E (TTM)
38.5x
Dividend yield (TTM)
4.87%
ROE
19.7%

Share price performance

Loading chart…

About Coloplast A/S

www.coloplast.com

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

Profile
Sector
Healthcare
Industry
Medical - Instruments & Supplies
HQ
Denmark
Fiscal year-end
September
Trading currency
DKK
Reporting currency
DKK
Fundamentals updated
5 days ago
Market
Market cap
$16.0B
Shares outstanding
225.4M
P/E (TTM)
38.5x
Dividend yield (TTM)
4.87%
Beta (issuer)
0.56
Revenue (latest FY)
DKK 27.9B

Revenue breakdown

Revenue split not available

FinScore

As of 2026-10-19
Overall62
Quality73
Growth40
Value56
Momentum71
Relative Strength78

Snapshot

Ownership

Free float
63.4%
Shares outstanding
225.4M

Holder data is not available for this company yet.

Sign up or log in to see Analysis

Analysis for Coloplast A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Financials

Financials for Coloplast A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Estimates

Estimates for Coloplast A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Peers

Peers for Coloplast A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Valuation

Valuation for Coloplast A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see News

News for Coloplast A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.